Current Portfolio
SpliceBio
SpliceBio is a genetic medicines company developing next-generation gene therapies using its proprietary Protein Splicing platform. The technology, built on over two decades of research from the Muir Lab at Princeton University, enables efficient delivery of large genes previously inaccessible to conventional gene therapy.
Key Facts
- Sector
Life Sciences
- Country
Spain
- Fund
LSP 7
- Entry
2025
Website


Responsible Partner
Do You Want to Know More?
We are eager to explore how we can achieve great things together.



